Molecular Target in CNS Malignancies
01About This Special Issue
With advancement of gene technology, molecular signatures have become prominent in the classification of gliomas in recent years. Whole-genome analysis of patient cases through The Cancer Genome Atlas (TCGA), revealed a molecular classification scheme for GBM which includes four molecular subtypes: proneural, neural, classical, and mesenchymal. Among these four subtypes, the mesenchymal subtype was distinguished from the others as being particularly aggressive. Thus, there is an urgent need for the exploration of novel biomarkers and therapeutic targets for brain tumor, especially GBM.
The special issue “Molecular Target in CNS malignancies” aims to highlight the significant findings and advances in our understanding of the role of the novel molecular targets, diagnostic biomarkers as well as novel prognostic indicators in CNS malignancies, especially GBM.
The special issue “Molecular Target in CNS malignancies” will provide an important forum for exciting findings in Neuro-oncology-related research, presenting an unparalleled opportunity to communicate information to specialists and the public, opening new avenues for the understanding, prevention, diagnosis and treatment of brain tumor patients.
Aims and Scope:
- Molecular targeted therapies
- Prognostic indicators of CNS malignancies
- Clinical trials and pre-clinical studies of neuro-oncology
- Cancer antigens and immune checkpoint
- Molecular mechanisms of drug resistance in CNS malignancies
- RNA-seq and proteomics study of CNS malignancies
02Meet the Guest Editors
Our distinguished editors bring deep subject-matter expertise to curate high-quality research and ensure a rigorous peer-review process.
Lead Guest Editor
Mingzhi Han
University of Bergen, Bergen, Norway
Guest Editor
Shuai Wang
Shandong University, Jinan, China
Guest Editor
Wenbo Zhao
Shandong University, Jinan, China
Guest Editor
Bin Huang
Shandong University, Jinan, China
Guest Editor
Ya Zhang
Shandong University, Jinan, China
Guest Editor
Yang Kong
Shandong University, Jinan, China
Guest Editor
Yuzhen Wei
Jining Hospital, Jinan, China


